Jane Street
RNAM

Jane Street’s Avidity Biosciences RNAM Stock Holding History

Jane Street’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,400
Closed -$3.13M – 12779
2025
Q4 		$3.13M Sell
43,400
-15,100
-26% -$975K ﹤0.01% 3972
2025
Q3 		$2.55M Buy
58,500
+45,600
+353% +$1.84M ﹤0.01% 4491
2025
Q2 		$366K Sell
12,900
-2,700
-17% -$80.5K ﹤0.01% 7489
2025
Q1 		$461K Buy
15,600
+3,700
+31% +$115K ﹤0.01% 7028
2024
Q4 		$346K Sell
11,900
-4,100
-26% -$171K ﹤0.01% 7494
2024
Q3 		$735K Sell
16,000
-9,700
-38% -$421K ﹤0.01% 6515
2024
Q2 		$1.05M Buy
+25,700
New +$737K ﹤0.01% 5669
2023
Q1 		– Sell
-89,700
Closed -$1.99M – 9783
2022
Q4 		$1.99M Buy
+89,700
New +$1.34M ﹤0.01% 3875

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Jane Street's RNAM Position: Q1 2026 in Review

Jane Street sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,734 shares — an estimated $341K sold.

Jane Street first reported a position in RNAM in Q2 2020 and held it in 16 quarters. The position peaked at $6.62M in Q2 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Jane Street reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 4,734 Avidity Biosciences shares in Q1 2026, an estimated $341K.
  • Jane Street first reported a position in Avidity Biosciences in Q2 2020 and held it in 16 quarters.
  • Jane Street's Avidity Biosciences position peaked at $6.62M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.